Abstract:Shikimic acid is an important intermediate for the manufacture of the antiviral drug oseltamivir (Tamiflu®) and many other pharmaceutical compounds. Much of its existing supply is obtained from the seeds of Chinese star anise (Illicium verum). Nevertheless, plants cannot supply a stable source of affordable shikimate along with laborious and cost-expensive extraction and purification process. Microbial biosynthesis of shikimate through metabolic engineering and synthetic biology approaches represents a sustainable, cost-efficient, and environmentally friendly route than plant-based methods. Metabolic engineering allows elevated shikimate production titer by inactivating the competing pathways, increasing intracellular level of key precursors, and overexpressing rate-limiting enzymes. The development of synthetic and systems biology-based novel technologies have revealed a new roadmap for the construction of high shikimate-producing strains. This review elaborates the enhanced biosynthesis of shikimate by utilizing an array of traditional metabolic engineering along with novel advanced technologies. The first part of the review is focused on the mechanistic pathway for shikimate production, use of recombinant and engineered strains, improving metabolic flux through the shikimate pathway, chemically inducible chromosomal evolution, and bioprocess engineering strategies. The second part discusses a variety of industrially pertinent compounds derived from shikimate with special reference to aromatic amino acids and phenazine compound, and main engineering strategies for their production in diverse bacterial strains. Towards the end, the work is wrapped up with concluding remarks and future considerations.

Expanding the repertoire of aromatic chemicals by microbial production: Microbial production of aromatic chemicals

Metabolic engineering of microorganisms for production of aromatic compounds

Recent Advances in Metabolically Engineered Microorganisms for the Production of Aromatic Chemicals Derived From Aromatic Amino Acids

Building microbial factories for the production of aromatic amino acid pathway derivatives: From commodity chemicals to plant-sourced natural products

Engineering Cyanobacteria for the Production of Aromatic Natural Products

Biotechnological production of specialty aromatic and aromatic-derivative compounds

Bioprocess Optimization for the Production of Aromatic Compounds With Metabolically Engineered Hosts: Recent Developments and Future Challenges

Microbial production of aromatic compounds and synthesis of high-performance bioplastics

Metabolic Engineering Ofescherichia Colifor Production of Chemicals Derived from the Shikimate Pathway

Metabolic Engineering of Escherichia Coli for Production of Chemicals Derived from the Shikimate Pathway.

Metabolic Engineering Strategies for Sustainable Terpenoid Flavor and Fragrance Synthesis

Current state of aromatics production using yeast: achievements and challenges

Synthetic biology for the synthesis of aromatic natural products:a review

Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites

[Enzyme engineering in microbial biosynthesis of terpenoids: progress and perspectives].

Engineering Microbial Factories for Synthesis of Value-Added Products

Metabolic engineering strategies for enhanced shikimate biosynthesis: current scenario and future developments

Efficient production of chemicals from microorganism by metabolic engineering and synthetic biology

The biosynthesis of L -phenylalanine-derived compounds by engineered microbes

Pathway engineering for the production of heterologous aromatic chemicals and their derivatives in Saccharomyces cerevisiae: bioconversion from glucose

Metabolic engineering of microbes for monoterpenoid production